Olfactory deficit detected by fMRI in early Alzheimer's disease

Alzheimer's disease (AD) is accompanied by smell dysfunction, as measured by psychophysical tests. Currently, it is unknown whether AD-related alterations in central olfactory system neural activity, as measured by functional magnetic resonance imaging (fMRI), are detectable beyond those observed in healthy elderly. Moreover, it is not known whether such changes are correlated with indices of odor perception and dementia. To investigate these issues, 12 early stage AD patients and 13 nondemented controls underwent fMRI while being exposed to each of three concentrations of lavender oil odorant. All participants were administered the University of Pennsylvania Smell Identification Test (UPSIT), the Mini-Mental State Examination (MMSE), the Mattis Dementia Rating Scale-2 (DRS-2), and the Clinical Dementia Rating Scale (CDR). The blood oxygen level-dependent (BOLD) signal at primary olfactory cortex (POC) was weaker in AD than in HC subjects. At the lowest odorant concentration, the BOLD signals within POC, hippocampus, and insula were significantly correlated with UPSIT, MMSE, DRS-2, and CDR scores. The BOLD signal intensity and activation volume within the POC increased significantly as a function of odorant concentration in the AD group, but not in the control group. These findings demonstrate that olfactory fMRI is sensitive to the AD-related olfactory and cognitive functional decline.

[1]  H. Critchley,et al.  Functional magnetic resonance imaging of odor identification: the effect of aging. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  S. Nordin,et al.  Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. , 1996 .

[3]  K. Davis,et al.  Olfactory identification deficits in relatives of Alzheimer's disease patients , 1996, Biological Psychiatry.

[4]  R. Doty,et al.  Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.

[5]  D. Yousem,et al.  The effect of age on odor-stimulated functional MR imaging. , 1999, AJNR. American journal of neuroradiology.

[6]  E. Kisch,et al.  Changes in serum dopamine-beta-hydroxylase activity during cold pressor test in subjects with high and low basal activity of this enzyme , 2005, Journal of Neural Transmission.

[7]  M. Serby,et al.  The nature and course of olfactory deficits in Alzheimer's disease. , 1991, The American journal of psychiatry.

[8]  H. Soininen,et al.  Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ϵ4 allele , 1995, Neurology.

[9]  D. G. Moulton,et al.  The performance of dogs in detecting α-ionone in the vapor phase , 2004, Journal of comparative physiology.

[10]  Christine Fennema-Notestine,et al.  Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study. , 2003, Journal of the International Neuropsychological Society : JINS.

[11]  R. Doty.  The olfactory vector hypothesis of neurodegenerative disease: Is it viable? , 2008, Annals of neurology.

[12]  H. Braak,et al.  Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[13]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  John F. Fulton,et al.  Medical physiology and biophysics , 1960 .

[15]  Thomas V. Getchell,et al.  Smell and Taste in Health and Disease , 1992, Annals of Internal Medicine.

[16]  H. Braak,et al.  Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.

[17]  H. Braak,et al.  Olfactory bulb changes in Alzheimer's disease , 2004, Acta Neuropathologica.

[18]  Justin L. Vincent,et al.  Disruption of Large-Scale Brain Systems in Advanced Aging , 2007, Neuron.

[19]  Qing X. Yang,et al.  Functional magnetic resonance imaging study of human olfaction and normal aging. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  D. Louis Collins,et al.  Design and construction of a realistic digital brain phantom , 1998, IEEE Transactions on Medical Imaging.

[21]  Richard L. Doty,et al.  Presence of both odor identification and detection deficits in alzheimer's disease , 1987, Brain Research Bulletin.

[22]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[23]  Karl J. Friston,et al.  Analysis of functional MRI time‐series , 1994, Human Brain Mapping.

[24]  B. Winblad,et al.  Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support. , 1999, Neuropsychology.

[25]  H. Soininen,et al.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[26]  G H Glover,et al.  Time course of odorant-induced activation in the human primary olfactory cortex. , 2000, Journal of neurophysiology.

[27]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[28]  W. F. Allen.  STUDIES ON THE LEVEL OF ANESTHESIA FOR THE OLFACTORY AND TRIGEMINAL RESPIRATORY REFLEXES IN DOGS AND RABBITS , 1936 .

[29]  M. Albert,et al.  Medial temporal lobe function and structure in mild cognitive impairment , 2004, Annals of neurology.

[30]  D. Kareken,et al.  Olfactory-evoked regional cerebral blood flow in Alzheimer's disease. , 2001, Neuropsychology.

[31]  Andrew J. Saykin,et al.  The Relationship between fMRI Activation and Cerebral Atrophy: Comparison of Normal Aging and Alzheimer Disease , 2000, NeuroImage.

[32]  David H. Zald,et al.  A computer-controlled olfactometer for fMRI and electrophysiological studies of olfaction , 1999, Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc.

[33]  P. Moberg,et al.  Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. , 1998, Archives of neurology.

[34]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[35]  D. G. Moulton,et al.  Studies in Olfactory Acuity: III. Relative Detectability of n-Aliphatic Acetates by the Rat , 1960 .

[36]  K. Jellinger,et al.  Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. , 2006, Clinical neuropathology.

[37]  R. Doty.  Odor Perception in Neurodegenerative Diseases , 2003 .

[38]  D. Devanand,et al.  Olfactory dysfunction as a predictor of neurodegenerative disease , 2006, Current neurology and neuroscience reports.

[39]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.